M. Committee-prof-bruno-riou, P. Samama, . Md, . Phd, M. Fccp-;-dr-karim-tazarourte et al., ) performed the statistical analysis. Local investigators (study group) and participating centers (emergency departments) are listed according to the number of patients included in the study

T. Gomes, M. Mamdani, A. Holbrook, J. Paterson, C. Hellings et al., Rates of hemorrhage during warfarin therapy for atrial fibrillation, Canadian Medical Association Journal, vol.185, issue.2, pp.121-127, 2013.
DOI : 10.1503/cmaj.121218

D. Wysowski, P. Nourjah, and L. Swartz, Bleeding Complications With Warfarin Use, Archives of Internal Medicine, vol.167, issue.13, pp.1414-1419, 2007.
DOI : 10.1001/archinte.167.13.1414

J. Huhtakangas, S. Tetri, S. Juvela, P. Saloheimo, M. Bode et al., Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage: A Longitudinal Population-Based Study, Stroke, vol.42, issue.9, pp.2431-2435, 2011.
DOI : 10.1161/STROKEAHA.111.615260

J. Flibotte, N. Hagan, O. Donnell, J. Greenberg, S. Rosand et al., Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage, Neurology, vol.63, issue.6, pp.1059-1064, 2004.
DOI : 10.1212/01.WNL.0000138428.40673.83

D. Dowlatshahi, K. Butcher, N. Asdaghi, S. Nahirniak, M. Bernbaum et al., Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal, Stroke, vol.43, issue.7, pp.1812-1817, 2012.
DOI : 10.1161/STROKEAHA.112.652065

E. Liotta and S. Prabhakaran, Warfarin-associated Intracerebral Hemorrhage is Increasing in Prevalence in the United States, Journal of Stroke and Cerebrovascular Diseases, vol.22, issue.7, pp.1151-1155, 2013.
DOI : 10.1016/j.jstrokecerebrovasdis.2012.11.015

B. Vigué, Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage ??? from theory to practice, Critical Care, vol.13, issue.2, p.209, 2009.
DOI : 10.1186/cc7701

R. Sarode, T. Milling, . Jr, M. Refaai, A. Mangione et al., Efficacy and Safety of a Four-Factor Prothrombin Complex Concentrate (4F-PCC) in Patients on Vitamin K Antagonists Presenting with Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study, Circulation, vol.128, pp.1234-1243, 2013.
DOI : 10.1161/CIRCULATIONAHA.113.002283

B. Vigué, C. Ract, B. Tremey, N. Engrand, P. Leblanc et al., Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage, Intensive Care Medicine, vol.12, issue.4, pp.721-725, 2007.
DOI : 10.1007/s00134-007-0528-z

G. Pernod, A. Godier, C. Gozalo, B. Tremey, and P. Sié, French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding), Thrombosis Research, vol.126, issue.3
DOI : 10.1016/j.thromres.2010.06.017

A. Holbrook, S. Schulman, D. Witt, P. Vandvik, J. Fish et al., Evidence-Based Management of Anticoagulant Therapy, Chest, vol.141, issue.2, pp.152-184, 2012.
DOI : 10.1378/chest.11-2295

D. Spahn, B. Bouillon, V. Cerny, T. Coats, J. Duranteau et al., Management of bleeding and coagulopathy following major trauma: an updated European guideline, Critical Care, vol.17, issue.2, p.76, 2013.
DOI : 10.1186/cc12685

J. Weitz, J. Eikelboom, and M. Samama, New Antithrombotic Drugs, Chest, vol.141, issue.2, pp.120-151, 2012.
DOI : 10.1378/chest.11-2294

E. Von-elm, D. Altman, M. Egger, S. Pocock, P. Gøtzsche et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement, Epidemiology, vol.18, issue.6, pp.1453-1457, 2007.
DOI : 10.1097/EDE.0b013e3181577654

T. Desmettre, A. Dubart, G. Capellier, B. Fanara, M. Puyraveau et al., Emergency reversal of anticoagulation: The real use of prothrombin complex concentrates, Thrombosis Research, vol.130, issue.3, pp.178-183, 2006.
DOI : 10.1016/j.thromres.2012.05.029

URL : https://hal.archives-ouvertes.fr/hal-00825707

B. Tremey, K. Tazarourte, C. Ract, M. Gabteni, L. Lavagna et al., Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department, Intensive Care Medicine, vol.164, issue.8, pp.1444-1448, 2009.
DOI : 10.1007/s00134-009-1465-9

J. Menzin, J. Hoesche, M. Friedman, C. Nichols, G. Bergman et al., Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records, Journal of Thrombosis and Haemostasis, vol.10, issue.4, pp.596-605, 2012.
DOI : 10.1111/j.1538-7836.2012.04636.x

K. Tanaka, F. Szlam, G. Dickneite, and J. Levy, Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation, Thrombosis Research, vol.122, issue.1, pp.117-123, 2008.
DOI : 10.1016/j.thromres.2007.09.002

A. Gatt, A. Riddell, J. Van-veen, S. Kitchen, and E. Tuddenham, study, Journal of Thrombosis and Haemostasis, vol.19, issue.7, pp.1123-1127, 2009.
DOI : 10.1111/j.1538-7836.2009.03435.x

URL : https://hal.archives-ouvertes.fr/hal-01242373

A. Qureshi, A. Mendelow, and D. Hanley, Intracerebral haemorrhage, The Lancet, vol.373, issue.9675, pp.1632-1644, 2009.
DOI : 10.1016/S0140-6736(09)60371-8

F. Dentali, C. Marchesi, M. Pierfranceschi, M. Crowther, D. Garcia et al., Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists, Thrombosis and Haemostasis, vol.106, issue.3, pp.429-438, 2011.
DOI : 10.1160/TH11-01-0052

A. Zubkov, J. Mandrekar, D. Claassen, E. Manno, E. Wijdicks et al., Predictors of Outcome in Warfarin-Related Intracerebral Hemorrhage, Archives of Neurology, vol.65, issue.10, pp.1320-1325, 2008.
DOI : 10.1001/archneur.65.10.1320

D. Zahuranec, D. Brown, L. Lisabeth, N. Gonzales, P. Longwell et al., Early care limitations independently predict mortality after intracerebral hemorrhage, Neurology, vol.68, issue.20, pp.1651-1657, 2007.
DOI : 10.1212/01.wnl.0000261906.93238.72

T. Desmettre, E. Dehours, C. Samama, S. Jhundoo, F. Pujeau et al., Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice, Critical Care, vol.16, issue.5, p.185, 2012.
DOI : 10.1002/ajh.21046

URL : https://hal.archives-ouvertes.fr/hal-00825705